Employees
~500
Therapeutic Areas
Infectious Diseases
Stage
Preclinical
Modalities
Small molecule

Helmholtz Institute for Pharmaceutical Research Saarland General Information

Research institute focused on developing novel anti-infectives by combining medicinal chemistry and natural product research with innovative drug delivery approaches. Currently has multiple pre-clinical candidates for various infectious diseases.

Contact Information

Website
Primary Industry
Academic
Corporate Office
Saarbrücken, Saarland
Germany

Drug Pipeline

darobactin
Pre-clinical
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Helmholtz Institute for Pharmaceutical Research Saarland's pipeline data

Book a demo

Key Partnerships

Evotec, Bill & Melinda Gates Foundation, Saarland University, BioVersys AG, Terrapeutics Pharma

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Helmholtz Institute for Pharmaceutical Research Saarland Funding

Deal TypeDateAmountStatusStage
Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Helmholtz Institute for Pharmaceutical Research Saarland's complete valuation and funding history, request access »